Abstract
Molecular imaging is at the forefront in the advancement of in-vivo diagnosis and monitoring of cancer. New peptide-based molecular probes to facilitate cancer detection are rapidly evolving. Peptide-based molecular probes that target apoptosis, angiogenesis, cell signaling and cell adhesion events are in place. Bacteriophage (phage) display technology, a molecular genetic approach to ligand discovery, is commonly employed to identify peptides as tumor-targeting molecules. The peptide itself may perhaps have functional properties that diminish tumor growth or metastasis. More often, a selected peptide is chemically synthesized, coupled to a radiotracer or fluorescent probe, and utilized in the development of new noninvasive molecular imaging probes. A myriad of peptides that bind cancer cells and cancer-associated antigens have been reported from phage library selections. Phage selections have also been performed in live animals to obtain peptides with optimal stability and targeting properties in vivo. To this point, few in-vitro, in-situ, or in-vivo selected peptides have shown success in the molecular imaging of cancer, the notable exception being vascular targeting peptides identified via in-vivo selections. The success of vasculature targeting peptides, such as those with an RGD motif that bind αvβ3integrin, may be due to the abundance and expression patterns of integrins in tumors and supporting vasculature. The discovery of molecular probes that bind tumor-specific antigens has lagged considerably. One promising means to expedite discovery is through the implementation of selected phage themselves as tumor-imaging agents in animals.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aina OH, Sroka TC, Chen ML, Lam KS (2002) Therapeutic cancer targeting peptides. Biopolymers 66:184–199
Arap W, Pasqualini R, Ruoslahti E (1998) Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279:377–380
Arap W, Haedicke W, Bernasconi M, Kain R, Rajotte D, Krajewski S, Ellerby HM, Bredesen DE, Pasqualini R, Ruoslahti E (2002a) Targeting the prostate for destruction through a vascular address. ProcNatl Acad Sci USA 99:1527–1531
Arap W, Kolonin M, Trepel M, Lahdenranta J, Cardo-Vila M, Giordano RJ, Mintz PJ, Ardelt PU, Yao VJ, Vidal CI, Chen L, Flamm A, Valtanen H, Weavind LM, Hicks ME, Pollock RE, Botz GH, Bucana CD, Koivunen E, Cahill D, Troncoso P, Baggerly KA, Pentz RD, Do KA, Logothetis CJ, Pasqualini R (2002b) Steps toward mapping the human vasculature by phage display. Nat Med 8:121–127
Arap MA, Lahdenranta J, Mintz PJ, Hajitou A, Sarkis AS, Arap W, Pasqualini R (2004) Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Cancer Cell 6:275–284
Askoxylakis V, Zitzmann S, Mier W, Graham K, Kramer S, von Wegner F, Fink RH, Schwab M, Eisenhut M, Haberkorn U (2005) Preclinical evaluation of the breast cancer cell-binding peptide, p160. Clin Cancer Res 11:6705–6712
Askoxylakis V, Mier W, Zitzmann S, Ehemann V, Zhang J, Kramer S, Beck C, Schwab M, Eisenhut M, Haberkorn U (2006) Characterization and development of a peptide (p160) with affinity for neuroblastoma cells. J Nucl Med 47:981–988
Atwell S, Wells JA (1999) Selection for improved subtiligases by phage display. Proc Natl Acad Sci USA 96:9497–9502
Bakker WH, Krenning EP, Reubi JC, Breeman WA, Setyono-Han B, de Jong M, Kooij PP, Bruns C, van Hagen PM, Marbach P et al (1991) In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in rats. Life Sci 49:1593–1601
Barbas CF 3rd, Kang AS, Lerner RA, Benkovic SJ (1991) Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci USA 88:7978–7982
Behr TM, Gotthardt M, Barth A, Behe M (2001) Imaging tumors with peptide-based radioligands. Q J Nucl Med 45:189–200
Binetruy-Tournaire R, Demangel C, Malavaud B, Vassy R, Rouyre S, Kraemer M, Plouet J, Derbin C, Perret G, Mazie JC (2000) Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis. EMBO J 19:1525–1533
Bockmann M, Drosten M, Putzer BM (2005) Discovery of targeting peptides for selective therapy of medullary thyroid carcinoma. J Gene Med 7:179–188
Brown KC (2000) New approaches for cell-specific targeting: identification of cell-selective peptides from combinatorial libraries. Curr Opin Chem Biol 4:16–21
Cai W, Shin DW, Chen K, Gheysens O, Cao Q, Wang SX, Gambhir SS, Chen X (2006) Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett 6:669–676
Chen J, Cheng Z, Hoffman TJ, Jurisson SS, Quinn TP (2000) Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues. Cancer Res 60:5649–5658
Chen J, Tung CH, Allport JR, Chen S, Weissleder R, Huang PL (2005a) Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction. Circulation 111:1800–1805
Chen L, Zurita AJ, Ardelt PU, Giordano RJ, Arap W, Pasqualini R (2004) Design and validation of a bifunctional ligand display system for receptor targeting. Chem Biol 11:1081–1091
Chen X, Sievers E, Hou Y, Park R, Tohme M, Bart R, Bremner R, Bading JR, Conti PS (2005b) Integrin alpha v beta 3-targeted imaging of lung cancer. Neoplasia 7:271–9
Cheng Z, Wu Y, Xiong Z, Gambhir SS, Chen X (2005) Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice. Bioconjug Chem 16:1433–1441
Crameri R, Kodzius R (2001) The powerful combination of phage surface display of cDNA libraries and high throughput screening. Comb Chem High Throughput Screen 4:145–155
Ding H, Prodinger WM, Kopecek J (2006) Identification of CD21-binding peptides with phage display and investigation of binding properties of HPMA copolymer-peptide conjugates. Bioconjug Chem 17:514–523
Du B, Qian M, Zhou Z, Wang P, Wang L, Zhang X, Wu M, Zhang P, Mei B (2006) In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library. Biochem Biophys Res Commun 342:956–962
Edgar R, McKinstry M, Hwang J, Oppenheim AB, Fekete RA, Giulian G, Merril C, Nagashima K, Adhya S (2006) High-sensitivity bacterial detection using biotin-tagged phage and quantum-dot nanocomplexes. Proc Natl Acad Sci USA 103:4841–4845
Fan H, Duan Y, Zhou H, Li W, Li F, Guo L, Roeske RW (2002) Selection of peptide ligands binding to fibroblast growth factor receptor 1. IUBMB Life 54:67–72
Fleming TJ, Sachdeva M, Delic M, Beltzer J, Wescott CR, Devlin M, Lander RC, Nixon AE, Roschke V, Hilbert DM, Sexton DJ (2005) Discovery of high-affinity peptide binders to BLyS by phage display. J Mol Recognit 18:94–102
Fong S, Doyle MV, Goodson RJ, Drummond RJ, Stratton JR, McGuire L, Doyle LV, Chapman HA, Rosenberg S (2002) Random peptide bacteriophage display as a probe for urokinase receptor ligands. Biol Chem 383:149–158
Fukuda MN, Ohyama C, Lowitz K, Matsuo O, Pasqualini R, Ruoslahti E, Fukuda M (2000) A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells. Cancer Res 60:450–456
Funovics M, Montet X, Reynolds F, Weissleder R, Josephson L (2005) Nanoparticles for the optical imaging of tumor E-selectin. Neoplasia 7:904–911
Giordano RJ, Cardo-Vila M, Lahdenranta J, Pasqualini R, Arap W (2001) Biopanning and rapid analysis of selective interactive ligands. Nat Med 7:1249–1253
Glinsky VV, Huflejt ME, Glinsky GV, Deutscher SL, Quinn TP (2000) Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells. Cancer Res 60:2584–2588
Glinsky VV, Glinsky GV, Rittenhouse-Olson K, Huflejt ME, Glinskii OV, Deutscher SL, Quinn TP (2001) The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Res 61:4851–4857
Goldenberg DM (2002) Targeted therapy of cancer with radiolabeled antibodies. J Nucl Med 43:693–713
Goldenberg MM (1999) Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer. Clin Ther 21:309–318
Goodson RJ, Doyle MV, Kaufman SE, Rosenberg S (1994) High-affinity urokinase receptor antagonists identified with bacteriophage peptide display. Proc Natl Acad Sci US A 91:7129–7133
Hajitou A, Trepel M, Lilley CE, Soghomonyan S, Alauddin MM, Marini FC, 3rd, Restel BH, Ozawa MG, Moya CA, Rangel R, Sun Y, Zaoui K, Schmidt M, von Kalle C, Weitzman MD, Gelovani JG, Pasqualini R, Arap W (2006) A hybrid vector for ligand-directed tumor targeting and molecular imaging. Cell 125:385–398
Haubner R, Wester HJ (2004) Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies. Curr Pharm Des 10:1439–1455
Haubner R, Wester HJ, Burkhart F, Senekowitsch-Schmidtke R, Weber W, Goodman SL, Kessler H, Schwaiger M (2001) Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med 42:326–336
Heppeler A, Froidevaux S, Eberle AN, Maecke HR (2000) Receptor targeting for tumor localisation and therapy with radiopeptides. Curr Med Chem 7:971–994
Hetian L, Ping A, Shumei S, Xiaoying L, Luowen H, Jian W, Lin M, Meisheng L, Junshan Y, Chengchao S (2002) A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor. J Biol Chem 277:43137-43142
Houghten RA, Pinilla C, Blondelle SE, Appel JR, Dooley CT, Cuervo JH (1991) Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature 354:84–86
Houimel M, Schneider P, Terskikh A, Mach JP (2001) Selection of peptides and synthesis of pentameric peptabody molecules reacting specifically with ErbB-2 receptor. Int J Cancer 92: 748–755
Janssen ML, Oyen WJ, Dijkgraaf I, Massuger LF, Frielink C, Edwards DS, Rajopadhye M, Boonstra H, Corstens FH, Boerman OC (2002) Tumor targeting with radiolabeled alpha(v) beta(3) integrin binding peptides in a nude mouse model. Cancer Res 62:6146–6151
Jaye DL, Nolte FS, Mazzucchelli L, Geigerman C, Akyildiz A, Parkos CA (2003) Use of real-time polymerase chain reaction to identify cell- and tissue-type-selective peptides by phage display. Am J Pathol 162:1419–1429
Jaye DL, Geigerman CM, Fuller RE, Akyildiz A, Parkos CA (2004) Direct fluorochrome labeling of phage display library clones for studying binding specificities: applications in flow cytometry and fluorescence microscopy. J Immunol Methods 295:119–127
Karasseva N, Glinsky VV, Chen NX, Komatireddy R, Quinn TP (2002) Identification and characterization of peptides that bind human ErbB-2 selected from a bacteriophage display library. J Protein Chem 21:287–296
Ke SH, Coombs GS, Tachias K, Corey DR, Madison EL (1997) Optimal subsite occupancy and design of a selective inhibitor of urokinase. J Biol Chem 272:20456–20462
Kelly KA, Jones DA (2003) Isolation of a colon tumor specific binding peptide using phage display selection. Neoplasia 5:437–444
Kelly K, Alencar H, Funovics M, Mahmood U, Weissleder R (2004) Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide. Cancer Res 64:6247–6251
Kelly KA, Clemons PA, Yu AM, Weissleder R (2006a) High-throughput identification of phage-derived imaging agents. Mol Imaging 5:24–30
Kelly KA, Nahrendorf M, Yu AM, Reynolds F, Weissleder R (2006b) In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging. Mol Imaging Biol 8:201–207
Kennel SJ, Mirzadeh S, Hurst GB, Foote LJ, Lankford TK, Glowienka KA, Chappell LL, Kelso JR, Davern SM, Safavy A, Brechbiel MW (2000) Labeling and distribution of linear peptides identified using in vivo phage display selection for tumors. Nucl Med Biol 27:815–825
Kim JW, Wang XW (2003) Gene expression profiling of preneoplastic liver disease and liver cancer: a new era for improved early detection and treatment of these deadly diseases? Carcinogenesis 24:363–369
Kim Y, Lillo AM, Steiniger SC, Liu Y, Ballatore C, Anichini A, Mortarini R, Kaufmann GF, Zhou B, Felding-Habermann B, Janda KD (2006) Targeting heat shock proteins on cancer cells: selection, characterization, and cell-penetrating properties of a peptidic GRP78 ligand. Biochemistry 45:9434–9444
Koivunen E, Arap W, Rajotte D, Lahdenranta J, Pasqualini R (1999) Identification of receptor ligands with phage display peptide libraries. J Nucl Medi 40:883–888
Kolonin M, Pasqualini R, Arap W (2001) Molecular addresses in blood vessels as targets for therapy. Curr Opin Chem Biol 5:308–313
Kolonin MG, Bover L, Sun J, Zurita AJ, Do KA, Lahdenranta J, Cardo-Vila M, Giordano RJ, Jaalouk DE, Ozawa MG, Moya CA, Souza GR, Staquicini FI, Kunyiasu A, Scudiero DA, Holbeck SL, Sausville EA, Arap W, Pasqualini R (2006) Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries. Cancer Res 66:34–40
Koolpe M, Dail M, Pasquale EB (2002) An ephrin mimetic peptide that selectively targets the EphA2 receptor. J Biol Chem 277:46974–46979
Koolpe M, Burgess R, Dail M, Pasquale EB (2005) EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity. J Biol Chem 280: 17301–17311
Kridel SJ, Chen E, Kotra LP, Howard EW, Mobashery S, Smith JW (2001) Substrate hydrolysis by matrix metalloproteinase-9. J Biol Chem 276:20572–20578
Kuhnast B, Bodenstein C, Haubner R, Wester HJ, Senekowitsch-Schmidtke R, Schwaiger M, Weber WA (2004) Targeting of gelatinase activity with a radiolabeled cyclic HWGF peptide. Nucl Med Biol 31:337–344
Kumada Y, Nogami M, Minami N, Maehara M, Katoh S (2005) Application of protein-coupled liposomes to effective affinity screening from phage library. J Chromatogr A 1080:22–28
Kumar S, Quinn T, Deutscher S (2007) Evaluation of an 111In-radiolabeled peptide as a targeting and imaging agent for ErbB-2 receptor expressing breast carcinomas. Clin Cancer Res 13:6070–6079
Kwon S, Ke S, Houston JP, Wang W, Wu Q, Li C, Sevick-Muraca EM (2005) Imaging dose-dependent pharmacokinetics of an RGD-fluorescent dye conjugate targeted to alpha v beta 3 receptor expressed in Kaposi’s sarcoma. Mol Imaging 4:75–87
Landon LA, Harden W, Illy C, Deutscher SL (2004a) High-throughput fluorescence spectroscopic analysis of affinity of peptides displayed on bacteriophage. Anal Biochem 331:60–67
Landon LA, Zou J, Deutscher SL (2004b) Is phage display on target for developing peptide-based cancer drugs? Curr Drug Discov Technol 1:113–132
Liang S, Lin T, Ding J, Pan Y, Dang D, Guo C, Zhi M, Zhao P, Sun L, Hong L, Shi Y, Yao L, Liu J, Wu K, Fan D (2006) Screening and identification of vascular-endothelial-cell-specific binding peptide in gastric cancer. J Mol Med 84:764–773
Marik J, Lam KS (2005) Peptide and small-molecule microarrays. Methods Mol Biol 310:217–226
Martens CL, Cwirla SE, Lee RY, Whitehorn E, Chen EY, Bakker A, Martin EL, Wagstrom C, Gopalan P, Smith CW et al (1995) Peptides which bind to E-selectin and block neutrophil adhesion. J Biol Chem 270:21129–21136
Maruta F, Parker AL, Fisher KD, Hallissey MT, Ismail T, Rowlands DC, Chandler LA, Kerr DJ, Seymour LW (2002) Identification of FGF receptor-binding peptides for cancer gene therapy. Cancer Gene Therapy 9:543–552
Maruta F, Parker AL, Fisher KD, Murray PG, Kerr DJ, Seymour LW (2003) Use of a phage display library to identify oligopeptides binding to the lumenal surface of polarized endothelium by ex vivo perfusion of human umbilical veins. J Drug Target 11:53–59
McGuire MJ, Samli KN, Chang YC, Brown KC (2006) Novel ligands for cancer diagnosis: selection of peptide ligands for identification and isolation of B-cell lymphomas. Exp Hematol 34:443–452
Meredith RF, Bueschen AJ, Khazaeli MB, Plott WE, Grizzle WE, Wheeler RH, Schlom J, Russell CD, Liu T, LoBuglio AF (1994) Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49. J Nucl Med 35:1017–1022
Michon IN, Penning LC, Molenaar TJ, van Berkel TJ, Biessen EA, Kuiper J (2002) The effect of TGF-beta receptor binding peptides on smooth muscle cells. Biochem Biophys Res Commun 293:1279–1286
Newton JR, Kelly KA, Mahmood U, Weissleder R, Deutscher SL (2006) In vivo selection of phage for the optical imaging PC-3 human prostate carcinoma in mice. Neoplasia 8:772–780
Nowak JE, Chatterjee M, Mohapatra S, Dryden SC, Tainsky MA (2006) Direct production and purification of T7 phage display cloned proteins selected and analyzed on microarrays. Biotechniques 40:220–227
Orlova A, Magnusson M, Eriksson TL, Nilsson M, Larsson B, Hoiden-Guthenberg I, Widstrom C, Carlsson J, Tolmachev V, Stahl S, Nilsson FY (2006) Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res 66:4339–4348
Pakkala M, Jylhasalmi A, Wu P, Leinonen J, Stenman UH, Santa H, Vepsalainen J, Perakyla M, Narvanen A (2004) Conformational and biochemical analysis of the cyclic peptides which modulate serine protease activity. J Pept Sci 10:439–447
Pan W, Arnone M, Kendall M, Grafstrom RH, Seitz SP, Wasserman ZR, Albright CF (2003) Identification of peptide substrates for human MMP-11 (stromelysin-3) using phage display. J Biol Chem 278:27820–27827
Pasqualini R, Ruoslahti E (1996) Organ targeting in vivo using phage display peptide libraries. Nature 380:364–366
Peletskaya EN, Glinsky G, Deutscher SL, Quinn TP (1996) Identification of peptide sequences that bind the Thomsen-Friedenreich cancer-associated glycoantigen from bacteriophage peptide display libraries. Mol Divers 2:13–18
Peletskaya EN, Glinsky VV, Glinsky GV, Deutscher SL, Quinn TP (1997) Characterization of peptides that bind the tumor-associated Thomsen-Friedenreich antigen selected from bacteriophage display libraries. J Mol Biol 270:374–384
Ploug M, Østergaard S, Gårdsvoll H, Kovalski K, Holst-Hansen C, Holm A, Ossowski L, Danø K (2001) Peptide-derived antagonists of the urokinase receptor. Affinity maturation by combinatorial chemistry, identification of functional epitopes, and inhibitory effect on cancer cell intravasation. Biochemistry 40:12157–12168
Popkov M, Rader C, Barbas CF, 3rd (2004) Isolation of human prostate cancer cell reactive antibodies using phage display technology. J Immunol Methods 291:137–151
Rahim A, Coutelle C, Harbottle R (2003) High-throughput pyrosequencing of a phage display library for the identification of enriched target-specific peptides. Biotechniques 35:317–320, 322, 324
Rasmussen UB, Schreiber V, Schultz H, Mischler F, Schughart K (2002) Tumor cell-targeting by phage-displayed peptides. Cancer Gene Ther 9:606–612
Reubi JC (2003) Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev 24:389–427
Robinson P, Stuber D, Deryckere F, Tedbury P, Lagrange M, Orfanoudakis G (2005) Identification using phage display of peptides promoting targeting and internalization into HPV-transformed cell lines. J Mol Recognit 18:175–182
Romanov VI, Durand DB, Petrenko VA (2001) Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion. Prostate 47:239–251
Rusckowski M, Gupta S, Liu G, Dou S, Hnatowich DJ (2004) Investigations of a (99m)Tc-labeled bacteriophage as a potential infection-specific imaging agent. J Nucl Med 45:1201–1208
Samoylov AM, Samoylova TI, Hartell MG, Pathirana ST, Smith BF, Vodyanoy V (2002) Recognition of cell-specific binding of phage display derived peptides using an acoustic wave sensor. Biomol Eng 18:269–272
Shukla GS, Krag DN (2005) Phage display selection for cell-specific ligands: development of a screening procedure suitable for small tumor specimens. J Drug Target 13:7–18
Sivolapenko GB, Skarlos D, Pectasides D, Stathopoulou E, Milonakis A, Sirmalis G, Stuttle A, Courtenay-Luck NS, Konstantinides K, Epenetos AA (1998) Imaging of metastatic melanoma utilising a technetium-99m labelled RGD-containing synthetic peptide. Eur J Nucl Med 25:1383–1389
Skelton NJ, Chen YM, Dubree N, Quan C, Jackson DY, Cochran A, Zobel K, Deshayes K, Baca M, Pisabarro MT, Lowman HB (2001) Structure-function analysis of a phage display-derived peptide that binds to insulin-like growth factor binding protein 1. Biochemistry 40:8487–8498
Smith GP (1985) Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228:1315–1317
Souza GR, Christianson DR, Staquicini FI, Ozawa MG, Snyder EY, Sidman RL, Miller JH, Arap W, Pasqualini R (2006) Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents. Proc Natl Acad Sci USA 103:1215–1220
Spear MA, Breakefield XO, Beltzer J, Schuback D, Weissleder R, Pardo FS, Ladner R (2001) Isolation, characterization, and recovery of small peptide phage display epitopes selected against viable malignant glioma cells. Cancer Gene Ther 8:506–511
Stortelers C, Souriau C, van Liempt E, van de Poll ML, van Zoelen EJ (2002) Role of the N-terminus of epidermal growth factor in ErbB-2/ErbB-3 binding studied by phage display. Biochemistry 41:8732–8741
Su ZF, Liu G, Gupta S, Zhu Z, Rusckowski M, Hnatowich DJ (2002) In vitro and in vivo evaluation of a Technetium-99m-labeled cyclic RGD peptide as a specific marker of alpha(V)beta(3) integrin for tumor imaging. Bioconjugate Chem 13:561–570
Urbanelli L, Ronchini C, Fontana L, Menard S, Orlandi R, Monaci P (2001) Targeted gene transduction of mammalian cells expressing the HER2/neu receptor by filamentous phage. J Mol Biol 313:965–976
Van de Wiele C, Dumont F, Dierckx RA, Peers SH, Thornback JR, Slegers G, Thierens H (2001) Biodistribution and dosimetry of (99m)Tc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies. J Nucl Med 42:1722–1727
van der Flier A, Sonnenberg A (2001) Function and interactions of integrins. Cell Tissue Res 305:285–298
Vidal CI, Mintz PJ, Lu K, Ellis LM, Manenti L, Giavazzi R, Gershenson DM, Broaddus R, Liu J, Arap W, Pasqualini R (2004) An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patients. Oncogene 23:8859–8867
Virgolini I (1997) Mack Forster Award Lecture. Receptor nuclear medicine: vasointestinal peptide and somatostatin receptor scintigraphy for diagnosis and treatment of tumour patients. Eur J Clin Invest 27:793–800
Voss SD, DeGrand AM, Romeo GR, Cantley LC, Frangioni JV (2002) An integrated vector system for cellular studies of phage display-derived peptides. Anal Biochem 308:364–372
Walter G, Konthur Z, Lehrach H (2001) High-throughput screening of surface displayed gene products. Comb Chem High Throughput Screen 4:193–205
Waltz E (2006) After criticism, more modest cancer genome project takes shape. Nat Med 12:259
Wang W, Ke S, Wu Q, Charnsangavej C, Gurfinkel M, Gelovani JG, Abbruzzese JL, Sevick-Muraca EM, Li C (2004) Near-infrared optical imaging of integrin alphavbeta3 in human tumor xenografts. Mol Imaging 3:343–351
Weber WA, Haubner R, Vabuliene E, Kuhnast B, Wester HJ, Schwaiger M (2001) Tumor angiogenesis targeting using imaging agents. Q J Nucl Med 45:179–182
Yang SQ, Craik CS (1998) Engineering bidentate macromolecular inhibitors for trypsin and urokinase-type plasminogen activator. J Mol Biol 279:1001–1011
Ye Y, Bloch S, Xu B, Achilefu S (2006) Design, synthesis, and evaluation of near infrared fluorescent multimeric RGD peptides for targeting tumors. J Med Chem 49:2268–2275
Zitzmann S, Mier W, Schad A, Kinscherf R, Askoxylakis V, Kramer S, Altmann A, Eisenhut M, Haberkorn U (2005) A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy. Clin Cancer Res 11:139–146
Zou J, Dickerson MT, Owen NK, Landon LA, Deutscher SL (2004) Biodistribution of filamentous phage peptide libraries in mice. Mol Biol Rep 31:121–129
Zou J, Glinsky VV, Landon LA, Matthews L, Deutscher SL (2005) Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion. Carcinogenesis 26:309–318
Zurita AJ, Troncoso P, Cardo-Vila M, Logothetis CJ, Pasqualini R, Arap W (2004) Combinatorial screenings in patients: the interleukin-11 receptor alpha as a candidate target in the progression of human prostate cancer. Cancer Res 64:435–439
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Newton, J., Deutscher, S.L. (2008). Phage Peptide Display. In: Semmler, W., Schwaiger, M. (eds) Molecular Imaging II. Handbook of Experimental Pharmacology, vol 185/2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-77496-9_7
Download citation
DOI: https://doi.org/10.1007/978-3-540-77496-9_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-77449-5
Online ISBN: 978-3-540-77496-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)